BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qu N, Wang X, Meng Y, Shan F. Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis. Int Immunopharmacol 2019;75:105723. [PMID: 31408839 DOI: 10.1016/j.intimp.2019.105723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Montagna G, Gupta HV, Hannum M, Tan KS, Lee J, Scarpa JR, Plitas G, Irie T, McCormick PJ, Fischer GW, Morrow M, Mincer JS. Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer. Br J Anaesth 2021;126:367-76. [PMID: 33220939 DOI: 10.1016/j.bja.2020.10.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Huang H, He X, Huang X, Wang G, Xia Q, Du Z, Zhang Y. Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00833-3] [Reference Citation Analysis]
3 Huang H, Liu B, Qu N, Zhang S, Bai X, Handley M, Shan F. Research progress of opioid growth factor in immune-related diseases and cancer diseases. Int Immunopharmacol 2021;99:107713. [PMID: 34426103 DOI: 10.1016/j.intimp.2021.107713] [Reference Citation Analysis]